Compendium of Cancer Genome Aberrations

Changes

Volunteer Assignments and Opportunities (view source)

Revision as of 10:04, 16 June 2020

230 bytes added ,  10:04, 16 June 2020
no edit summary
Line 10: Line 10:  
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans, Fabiola Quintero-Rivera
 
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans, Fabiola Quintero-Rivera
 
|Fabiola Quintero-Rivera (FQR)
 
|Fabiola Quintero-Rivera (FQR)
−
|
+
|PENDING
 
|
 
|
 
|
 
|
Line 37: Line 37:  
|T. Niroshi  Senaratne
 
|T. Niroshi  Senaratne
 
|FQR
 
|FQR
−
|
+
|PENDING
 
|
 
|
 
|
 
|
Line 76: Line 76:  
|Shashi Shetty
 
|Shashi Shetty
 
|FQR
 
|FQR
−
|
+
|PENDING
 
|
 
|
 
|
 
|
Line 89: Line 89:  
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
 
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
 
|FQR
 
|FQR
−
|
+
|PENDING
 
|
 
|
 
|
 
|
Line 582: Line 582:  
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Honey Reddi
 
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Honey Reddi
 
|SP
 
|SP
−
|
+
|PENDING
 
|
 
|
 
|
 
|
Line 588: Line 588:  
|       Monoclonal B-cell  Lymphocytosis||Disease||Honey Reddi
 
|       Monoclonal B-cell  Lymphocytosis||Disease||Honey Reddi
 
|SP
 
|SP
−
|
+
|PENDING
 
|
 
|
 
|
 
|
Line 594: Line 594:  
|B-cell Prolymphocytic Leukemia||Disease||Honey Reddi
 
|B-cell Prolymphocytic Leukemia||Disease||Honey Reddi
 
|SP
 
|SP
−
|
+
|PENDING
 
|
 
|
 
|
 
|
Line 612: Line 612:  
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
 
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
 
|SP
 
|SP
−
|
+
|PENDING
 
|
 
|
 
|Malini to review
 
|Malini to review
Line 618: Line 618:  
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
 
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
 
|SP
 
|SP
−
|
+
|PENDING
 
|
 
|
 
|Malini to review
 
|Malini to review
Line 630: Line 630:  
|Lymphoplasmacytic Lymphoma||Disease||Honey Reddi
 
|Lymphoplasmacytic Lymphoma||Disease||Honey Reddi
 
|SP
 
|SP
−
|
+
|PENDING
 
|
 
|
 
|
 
|
Line 636: Line 636:  
|   Waldenstrom  Macroglobulinemia||Disease||Honey Reddi
 
|   Waldenstrom  Macroglobulinemia||Disease||Honey Reddi
 
|SP
 
|SP
−
|
+
|PENDING
 
|
 
|
 
|
 
|
Line 667: Line 667:  
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
 
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
 
|SP
 
|SP
−
|
+
|PENDING
 
|
 
|
 
|
 
|
Line 673: Line 673:  
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
 
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
 
|SP
 
|SP
−
|
+
|PENDING
 
|
 
|
 
|
 
|
Line 679: Line 679:  
|    Plasma Cell Myeloma||Disease||Zhenya Tang
 
|    Plasma Cell Myeloma||Disease||Zhenya Tang
 
|SP
 
|SP
−
|
+
|PENDING
 
|
 
|
 
|
 
|
Line 685: Line 685:  
|    Plasma Cell Myeloma  Variants||Disease||Zhenya Tang
 
|    Plasma Cell Myeloma  Variants||Disease||Zhenya Tang
 
|SP
 
|SP
−
|
+
|PENDING
 
|
 
|
 
|
 
|
Line 691: Line 691:  
|    Plasmacytoma||Disease||Zhenya Tang
 
|    Plasmacytoma||Disease||Zhenya Tang
 
|SP
 
|SP
−
|
+
|PENDING
 
|
 
|
 
|
 
|
Line 727: Line 727:  
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease||Zhenya Tang & Trainee
 
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease||Zhenya Tang & Trainee
 
|SP
 
|SP
−
|
+
|PENDING
 
|
 
|
 
|
 
|
Line 778: Line 778:  
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
 
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
 
|SP
 
|SP
−
|
+
|PENDING
 
|
 
|
 
|
 
|
Line 784: Line 784:  
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||Mahsa Khanlari
 
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||Mahsa Khanlari
 
|SP
 
|SP
−
|
+
|PENDING
 
|
 
|
 
|
 
|
Line 790: Line 790:  
|    In Situ Mantle Cell  Neoplasia||Disease||Mahsa Khanlari
 
|    In Situ Mantle Cell  Neoplasia||Disease||Mahsa Khanlari
 
|SP
 
|SP
−
|
+
|PENDING
 
|
 
|
 
|
 
|
Line 860: Line 860:  
|-
 
|-
 
|Plasmablastic Lymphoma||Disease||Mark Evans, Fabiola Quintero-Rivera||GC
 
|Plasmablastic Lymphoma||Disease||Mark Evans, Fabiola Quintero-Rivera||GC
−
|completed
+
|Complete
 
|
 
|
 
|
 
|
Line 930: Line 930:  
|-
 
|-
 
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don||SP
 
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don||SP
−
|
+
|PENDING
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don||SP
 
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don||SP
−
|
+
|PENDING
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don||SP
 
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don||SP
−
|
+
|PENDING
 
|
 
|
 
|
 
|
Line 986: Line 986:  
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan
 
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan
 
|SP
 
|SP
−
|
+
|PENDING
 
|
 
|
 
|
 
|
Line 992: Line 992:  
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan
 
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan
 
|SP
 
|SP
−
|
+
|PENDING
 
|
 
|
 
|
 
|
Line 998: Line 998:  
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
 
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
 
|SP
 
|SP
−
|
+
|PENDING
 
|
 
|
 
|
 
|
Line 1,004: Line 1,004:  
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan
 
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan
 
|SP
 
|SP
−
|
+
|PENDING
 
|
 
|
 
|
 
|
Line 1,010: Line 1,010:  
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan
 
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan
 
|SP
 
|SP
−
|
+
|PENDING
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don||SP
 
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don||SP
−
|
+
|PENDING
 
|
 
|
 
|
 
|
Line 1,101: Line 1,101:  
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
 
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
 
|SP
 
|SP
−
|
+
|PENDING
 
|
 
|
 
|
 
|
Line 1,107: Line 1,107:  
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
 
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
 
|SP
 
|SP
−
|
+
|PENDING
 
|
 
|
 
|
 
|
Line 1,113: Line 1,113:  
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
 
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
 
|SP
 
|SP
−
|
+
|PENDING
 
|
 
|
 
|
 
|
Line 1,181: Line 1,181:  
Fabiola Quintero-Rivera
 
Fabiola Quintero-Rivera
 
|
 
|
−
|
+
|PENDING
 
|
 
|
 
|
 
|
Retrieved from "https://ccga.io/index.php/Special:MobileDiff/8163"